Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Non-Hodgkin 3Lymphoma, B-Cell 2Lymphoma 2Triple Negative Breast Neoplasms 1Neuroblastoma 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Leukemia 1Hodgkin Disease 1Hematologic Diseases 1Ganglioneuroblastoma 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 7Mycophenolic Acid 5Whole-Body Irradiation 4Busulfan 4fludarabine phosphate 3fludarabine 3Tacrolimus 3Rituximab 3Prednisone 3Methotrexate 3Inotuzumab Ozogamicin 3Etoposide 3Cytarabine 3Cyclosporine 3venetoclax 2ruxolitinib 2pegfilgrastim 2asciminib 2Vincristine 2Peripheral Blood Stem Cell Transplantation 2Mercaptopurine 2Filgrastim 2Dexamethasone 2Calcium Dobesilate 2tocilizumab 1ricolinostat 1rasburicase 1ponatinib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Leukapheresis × 30 days × Clear all
NCT03226704 2026-05-20

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
120 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡